Patent Search and Filing

A perpetual-motion machine may defy the laws of physics, but an Indiana inventor recently succeeded in having one patented…[more]

PARI has been granted US Patent 6,962,151 relating to technological advances in the eFlow electronic nebulizer that result in significant improvements in aerosol medication delivery. This technology aerosolizes medication more efficiently, so patients experience dramatically shorter treatment times while receiving complete therapies…[more]

HP plays the patent game (CNET)
More people than ever are hitting HP up for money for patents, but the company is getting more out of its own patent portfolio as well.

Judge sees stay unlikely in RIM patent case (Reuters via Yahoo! News)
Research in Motion Ltd., maker of the BlackBerry handheld e-mail device, suffered a setback in a potentially damaging patent infringement suit when a judge said on Wednesday he was unlikely to await a U.S. patent office review.

Red Hat has joined four other technology companies in creating a patent holding company that will buy Linux-related patents and license them to users without charge…[more]

BASF finds all’s fair for patent injunctions (Financial Times)
BASF, the world s biggest chemicals producer, together with two other companies, slapped more than three dozen injunctions on Chinese rivals because of alleged patent infringements at Europe s biggest agrochemicals trade fair in Glasgow last week.

Qualcomm sues Nokia for patent infringement (telecomasia.net)
Qualcomm has filed a lawsuit in a US federal court against Nokia for patent infringement. Eleven of the patents in question are the property of Qualcomm, and one patent belongs to Snaptrack, Qualcomm’s wholly owned subsidiary, the company said.

Despite Court Win, Merck Outlook Gloomy (ABC News)
Despite Court Win in Vioxx Liability Case, Merck Outlook Gloomy With Patent and Pipeline Problems

Ranbaxy granted permission to appeal UK HC judgement on Lipitor patent (PharmaBiz)
The U K High Court granted the Ranbaxy Laboratories permission to appeal the ruling of October 12, 2005 that its atorvastatin product would infringe Warner Lambert/Pfizer’s European patent 247 633 in the UK, a company release stated here.

Despite Court Win, Merck Outlook Gloomy (ABC News)
Despite Court Win in Vioxx Liability Case, Merck Outlook Gloomy With Patent and Pipeline Problems